Gram-negative bacteraemia: new therapeutic possibilities with anti-endotoxin antibodies.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D002415:Cats; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004731:Endotoxins / Q000276:immunology*; D005260:Female; D006090:Gram-Negative Bacteria / Q000472:pathogenicity*; D006736:Horses / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy; D008070:Lipopolysaccharides / Q000276:immunology; D051379:Mice; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D018805:Sepsis / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D012771:Shock, Hemorrhagic / Q000628:therapy; D012772:Shock, Septic / Q000628:therapy
D000888:Antibodies, Anti-Idiotypic; D004731:Endotoxins; D008070:Lipopolysaccharides